Check heart disease risk and monitor changes over time
Part of Heart & circulation clinical trials.
This study helps test a prevention plan for people who are at higher risk of heart disease. It uses regular monitoring to see if early prevention can reduce risk before heart problems happen.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Live in China’s Yinzhou District and have a unique health ID
- Be between 40 and 79 years old when you enroll
- Have a high heart disease risk score (10-year risk of 10% or more)
- Have NOT had coronary heart disease, stroke, or heart failure in the past
- No current cancer diagnosis
- Be willing to sign written consent to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at early signs of heart and kidney damage in Chinese adults and uses digital tools to help manage risk. It may help you understand your cardiovascular health better and get support to stay healthy.
This trial looks at how learning about your genetic risk for heart disease might help prevent it. You will get a personalized report and guidance.
This study looks for new body markers (including possible genetic traits) to better predict who is likely to have future cardiovascular events. Your results could help doctors estimate risk and choose prevention strategies more accurately.
This study looks at how to better sort people with heart disease into different risk groups. You may be asked for information about your heart condition and related health to help guide future care.
This study looks at whether changing your immune system, fats, and metabolism can lower your risk of early heart disease. It is for people with an intermediate to high risk score but who have not yet had a heart attack or stroke.
This study follows people with heart failure over time to record outcomes like illness course and death, and to understand how treatments affect results. If you have heart failure and can join regular check-ins, your information may help improve future care.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.